Strain Information | |
---|---|
Image | |
BRC No. | RBRC12085 |
Type | Transgene Congenic |
Species | Mus musculus |
Strain name | D1.Cg-Tg(Col2a1-CIITA)1Skncu Tg(Col2a1-Cd80)1Skncu |
Former Common name | D1CC x D1BC (DBA/1, Collagen type II promoter/ enhancer-driven CIITA, DBA/1, the B7.1 gene is transcribed from the rat collagen Type II promoter and enhancer) |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | |
Strain description | |
Colony maintenance | |
References | JBMR Plus, 3(6):e10132 (2019). 31346564 Proc. Natl. Acad. Sci. USA, 103(39):14465-70 (2006). 16980409 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter CIITAclass II transactivatorUNCIITA Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Cd80CD80 antigenUNCd80 |
Ordering Information | |
---|---|
Donor DNA | ヒト CIITA(cDNA): D1CC locus, ウサギ Globin splicing sequence: D1CC locus, ラット Type II collagen Promoter, enhancer: D1CC and D1BClocus, ウシシミアンウイルス 40 PolyA: D1CC and D1BC locus, インフルエンザウイルス HA: D1CC locus, Klebsella pneumonia Neomycin 耐性遺伝子: D1CC locus, ラット、マウス B7.1(cDNA+CIITA PolyA): D1BC locusStreptomyces alboniger Puromycin 耐性遺伝子: D1BC locus |
Research application | |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Proc. Natl. Acad. Sci. U S A., 103(39):14465-70 (2006). JBMR Plus, 3(6):e10132 (2019). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Satoshi Kanazawa (Nagoya City University) |
Strain Status | Live mice |
Strain Availability | Recovery and QC required prior to distribution |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |